Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University

by Kim Nunley | Feb 13, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, Feb. 13, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Issues Update on Intellectual Property and Newly Acquired Patents

by Kim Nunley | Jan 23, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, Jan. 23, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Secures New INCI Name for Its Prospective Anti-Inflammatory and Antioxidant Ingredient Atopidine™

by Kim Nunley | Jan 8, 2020 | Kannalife Sciences, Press Releases

SAN DIEGO, Jan. 8, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Commences Trading on OTCQB Under Ticker Symbol “KLFE”

by Kim Nunley | Dec 10, 2019 | Kannalife Sciences, Press Releases

SAN DIEGO, Dec. 10, 2019 /PRNewswire/ — Medical Marijuana, Inc. (the “Company”) (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products,...

Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research on CBD and Chemotherapy-Induced Peripheral Neuropathy

by Jeffrey Stamberger | May 23, 2019 | Kannalife Sciences, Press Releases

SAN DIEGO, May 23, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Benzinga, ABC News, and More Feature Medical Marijuana, Inc. Companies This Week

by Jeffrey Stamberger | Mar 6, 2019 | HempMeds, Kannalife Sciences, Kannaway, Media Coverage

CBD guidelines for physicians, UFC fighters and CBD, and using cannabinoids to protect NFL players among the topics our family of companies were featured around this week. News from across the Medical Marijuana, Inc. family of companies made headlines this week as the...